Efficacy of Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial. (2023). SKIN The Journal of Cutaneous Medicine, 7(6), s255. https://doi.org/10.25251/skin.7.supp.255